T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations. (2018)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.11.050

PubMed Identifier: 29355678

Publication URI: http://europepmc.org/abstract/MED/29355678

Type: Journal Article/Review

Volume: 142

Parent Publication: The Journal of allergy and clinical immunology

Issue: 3

ISSN: 0091-6749